中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
2026-07-15
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
Learn More
2026-07-03
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS
Learn More
2026-06-22
Tsoi Hoi Shan Attended Novo Nordisk Roundtable to Discuss the Global Impact of Chinese Innovation
Learn More
2026-06-12
APPROVAL FOR CLINICAL TRIAL OF THE GROUP’S PRODUCT TUL321 CAPSULES
Learn More
2026-05-20
APPROVAL FOR CLINICAL TRIAL OF GROUP’S PRODUCT TUL108 FOR INJECTION
Learn More
All News
Select Year
2026
2025
2024
The United Laboratories (Inner Mongolia) Co., Ltd. has obtained the production license and GMP acceptance for ampicillin veterinary medicine
2025-12-18
Zhuhai United Laboratories Co., Ltd. was selected as one of the "Top 500 Manufacturing Enterprises in Guangdong Province in 2025"
2025-12-18
TUL breaks through CPHI Frankfurt with ‘value'
2025-12-18
The production ceremony of Inner Mongolia Everbright Lianfeng Biotechnology Co., Ltd. was successfully held
2025-12-18
Leaders of Bayannur Municipal Government meet with Chairman of the Board of TUL Tsoi Hoi Shan
2025-12-18
TUL participated in the 30th MIF, and its biological research and development achievements attracted widespread attention
2025-12-18
UPDATED INFORMATION ON THE GROUP’S PRODUCT MOXIFLOXACIN HYDROCHLORIDE EYE DROPS
2025-12-10
UPDATED INFORMATION ON THE GROUP’S PRODUCT LEVOFLOXACIN EYE DROPS
2025-12-10
THE GROUP’S PRODUCT CEFOPERAZONE SODIUM AND SULBACTAM SODIUM FOR INJECTION PASSED THE CONSISTENCY EVALUATION
2025-12-02
Prev
1
...
4
5
6
7
8
...
17
Next
WeChat
Official
Account
To Top